Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Clogged, Blocked Oral Syringes and Feeding Tubes
MedSun: Newsletter #60, May 2011

FDA MedWatch Safety Alert

The FDA has received reports that Teva's lansoprazole delayed-release orally disintegrating tablet has clogged and blocked oral syringes and feeding tubes because the tablets may not fully disintegrate.

Additional Information:

FDA Medical Device Safety. Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals. April 15, 2011.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251575.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun